Clinical Trial Update: Identification of Hepatic Lesions [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial sponsored by Bayer evaluating hepatic neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Neoplasms

Snippet

Sponsor: Bayer | Conditions: Hepatic Neoplasms | Phase 3 | Status: COMPLETED